Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

AIMS: To determine the effects of empagliflozin on adiposity indices among patients with type 2 diabetes mellitus. METHODS: Changes in weight, waist circumference, estimated total body fat, index of central obesity and visceral adiposity index were assessed using analysis of covariance and testing o...

Descripción completa

Detalles Bibliográficos
Autores principales: Neeland, Ian J, McGuire, Darren K, Chilton, Robert, Crowe, Susanne, Lund, Søren S, Woerle, Hans J, Broedl, Uli C, Johansen, Odd Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768401/
https://www.ncbi.nlm.nih.gov/pubmed/26873905
http://dx.doi.org/10.1177/1479164115616901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768401/
https://www.ncbi.nlm.nih.gov/pubmed/26873905
http://dx.doi.org/10.1177/1479164115616901

Ejemplares similares